Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

MIRA Pharmaceuticals, Inc. (MIRA) vs Organon & Co. (OGN)

MIRA Pharmaceuticals, Inc. and Organon & Co. are both Drug Manufacturers General companies. Organon & Co. is the larger, with a market value of $3.6B against $35.3M — 102.0× the size. MIRA Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Organon & Co. trades at 17.4×. Organon & Co. has the higher net margin (3.41% vs 0.00%) and the higher return on invested capital (6.11% vs −12,016.1%). Across the 14 metrics below, Organon & Co. leads on 10 and MIRA Pharmaceuticals, Inc. on 4.

Valuation

Metric MIRA OGN Drug Manufacturers General median
P/E n/m 17.38 24.72
P/S n/m 0.59 3.35
P/B 4.63 3.58 5.00
Price to free cash flow n/m 7.77 17.68
EV/EBITDA n/m 7.82 13.91
EV/Sales n/m 1.80 3.95
Earnings yield (158.22%) 5.75% 2.92%
Free cash flow yield (12.27%) 12.87% 4.42%

Profitability

Metric MIRA OGN Drug Manufacturers General median
Gross margin — 52.68% 72.77%
Operating margin 0.00% 13.45% 18.90%
Net margin 0.00% 3.41% 8.27%
Free cash flow margin 0.00% 7.57% 17.25%
Return on equity (710.85%) 24.04% 6.97%
Return on assets (684.27%) 1.57% 2.76%
Return on invested capital (12,016.10%) 6.11% 6.30%

Growth

Metric MIRA OGN Drug Manufacturers General median
Revenue growth (TTM) — (2.45%) 6.79%
EPS growth (last fiscal year) (164.71%) (78.38%) —
Revenue growth, 5-year CAGR — (0.99%) 3.98%
Net income growth, 5-year CAGR 0.00% (38.70%) 0.42%

Health

Metric MIRA OGN Drug Manufacturers General median
Debt to equity 0.00 8.50 0.63
Current ratio 200.19 1.95 1.32
Net debt to EBITDA 1.05 5.62 1.15

Dividend

Metric MIRA OGN Drug Manufacturers General median
Dividend yield — 6.88% 3.57%
Payout ratio — 0.38 0.53

Size

Metric MIRA OGN Drug Manufacturers General median
Market cap 35.28m 3.60b 125.91b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack